Kenvue’s Weak Sales Give Power to Activist Push

Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty category slowed.

Organic sales rose 0.9 percent in the three months ended Sept. 29, the company said Thursday. Analysts projected growth of 1.7 percent, according to the average of estimates from Bloomberg.

The company said it expects organic sales growth toward the low end of its 2024 outlook of 2 percent to 4 percent, while maintaining its outlook for adjusted earnings per…